Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for National Healthcare (NHC) over the last 17 years, with Q3 2025 value amounting to $11.3 million.

  • National Healthcare's Change in Accured Expenses fell 2084.29% to $11.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.8 million, marking a year-over-year increase of 12769.28%. This contributed to the annual value of $5.0 million for FY2024, which is 5731.9% down from last year.
  • National Healthcare's Change in Accured Expenses amounted to $11.3 million in Q3 2025, which was down 2084.29% from $13.0 million recorded in Q2 2025.
  • National Healthcare's Change in Accured Expenses' 5-year high stood at $25.6 million during Q2 2021, with a 5-year trough of -$32.8 million in Q1 2022.
  • Its 5-year average for Change in Accured Expenses is $1.6 million, with a median of $4.2 million in 2023.
  • The largest annual percentage gain for National Healthcare's Change in Accured Expenses in the last 5 years was 23671.45% (2024), contrasted with its biggest fall of 20731.01% (2024).
  • National Healthcare's Change in Accured Expenses (Quarter) stood at $20.8 million in 2021, then tumbled by 123.26% to -$4.8 million in 2022, then surged by 49.61% to -$2.4 million in 2023, then tumbled by 207.31% to -$7.5 million in 2024, then skyrocketed by 251.34% to $11.3 million in 2025.
  • Its last three reported values are $11.3 million in Q3 2025, $13.0 million for Q2 2025, and $5.9 million during Q1 2025.